EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Low-dose interleukin-2 as a novel therapeutic option for refractory paraneoplastic neurologic syndrome: a case of chronic relapsing anti-Ma2/Ta paraneoplastic myeloradiculopathy

Seon-Jae Ahn, Han-Sang Lee, Woo-Jin Lee, Kon Chu iD

encephalitis · 2021

DOI: 10.47936/encephalitis.2021.00038 ↗

Kurz gefasst

Fallbericht in der Zeitschrift encephalitis, 2021. Verfasst von Seon-Jae Ahn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Hospital Medicine, Seoul National University Hospital, Seoul, Korea. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ildong Pharmaceutical Co., Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paraneoplastic neurologic syndromes (PNS) caused by anti-Ma2/Ta antibodies have diverse presentations. Myeloradiculopathy is one anti-Ma2/Ta-associated PNS manifestation. We report the case of a patient with chronic relapsing anti-Ma2/Ta paraneoplastic myeloradiculopathy. The patient was successfully treated with low-dose human recombinant interleukin-2, despite having chronic relapsing symptoms and a refractory response to conventional immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

Anti-Ma2/Ta paraneoplastic syndromeHuman recombinant interleukin-2MyeloradiculopathyParaneoplastic neurological syndromes

Autor:innen und Institutionen

  • Center for Hospital Medicine, Seoul National University Hospital, Seoul, Korea.
  • Department of Neurology, Comprehensive Epilepsy Center, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

ORCID-Profile: Kon Chu

Förderung

  • Ildong Pharmaceutical Co., Ltd

Zitieren

APA

Ahn, S. J., Lee, H. S., Lee, W. J., & Chu, K. (2021). Low-dose interleukin-2 as a novel therapeutic option for refractory paraneoplastic neurologic syndrome: a case of chronic relapsing anti-Ma2/Ta paraneoplastic myeloradiculopathy. encephalitis. https://doi.org/10.47936/encephalitis.2021.00038

Vancouver

Ahn SJ, Lee HS, Lee WJ, Chu K. Low-dose interleukin-2 as a novel therapeutic option for refractory paraneoplastic neurologic syndrome: a case of chronic relapsing anti-Ma2/Ta paraneoplastic myeloradiculopathy. encephalitis. 2021. doi:10.47936/encephalitis.2021.00038

BibTeX
@article{Ahn2021,
  author = {Ahn, Seon-Jae and Lee, Han-Sang and Lee, Woo-Jin and Chu, Kon},
  title = {Low-dose interleukin-2 as a novel therapeutic option for refractory paraneoplastic neurologic syndrome: a case of chronic relapsing anti-Ma2/Ta paraneoplastic myeloradiculopathy},
  journal = {encephalitis},
  year = {2021},
  doi = {10.47936/encephalitis.2021.00038}
}
Kostenlos starten →